0% found this document useful (0 votes)
157 views57 pages

Comprehensive Guide to Pulmonary Function Tests

Dr. Anand Patel is an assistant professor who specializes in cardio-respiratory pulmonary function tests. These tests measure lung volumes, capacities, and gas transfer to evaluate respiratory system function and identify pulmonary impairments. Key measurements include forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and their ratio. Obstructive conditions decrease FEV1/FVC while restrictive conditions usually do not affect the ratio. Spirometry is used to measure these values.

Uploaded by

Deepika Patel
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
157 views57 pages

Comprehensive Guide to Pulmonary Function Tests

Dr. Anand Patel is an assistant professor who specializes in cardio-respiratory pulmonary function tests. These tests measure lung volumes, capacities, and gas transfer to evaluate respiratory system function and identify pulmonary impairments. Key measurements include forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and their ratio. Obstructive conditions decrease FEV1/FVC while restrictive conditions usually do not affect the ratio. Spirometry is used to measure these values.

Uploaded by

Deepika Patel
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
  • Title Page: The front page with the document title and author's information.
  • Introduction: Discusses the purpose and application of pulmonary function tests in assessing respiratory system status.
  • Indications: Lists the reasons for conducting pulmonary function tests, including changes in function and therapeutic evaluation.
  • Contraindications: Outlines conditions under which pulmonary function tests should be avoided.
  • Lung Volumes and Capacities: Introduces and defines different lung volumes and capacities monitored in tests.
  • PFT Components: Lists the components of pulmonary function testing.
  • Maximal Voluntary Ventilation: Describes the maximal voluntary ventilation test and its significance.
  • Reversibility: Discusses the role of reversibility testing in observing treatment effects for airway obstruction.
  • Bronchoprovocation: Explains bronchoprovocation testing for assessing airway hyperreactivity.
  • Static Lung Volume Methods: Reviews methods for measuring functional residual capacity including helium dilution and plethysmography.
  • Diffusing Capacity: Focuses on measuring lung's capacity for gas transfer across membranes using specific methodologies.
  • Causes of Increased Dlco: Explores physiological and pathological causes of increased Dlco readings in patients.
  • Thank You: Concluding page with a thank you message.

Dr.

Anand Patel
M.P.T. Cardio-Respiratory
Assistant professor

PULMONARY FUNCTION
TEST
INTRODUCTION
• Pulmonary function tests or lung function tests are useful in assessing the
functional status of the respiratory system both in physiological and
pathological conditions.

• MEASURE:
(1) Dynamic flow rates of gases through the airways,
(2) Lung volumes and capacities, and
(3) The ability of the lungs to diffuse gases

• Identify the presence and type of pulmonary impairments and the degree of
pulmonary disease present.
INDICATIONS
• To identify and quantify changes in pulmonary function
• To evaluate need and quantify therapeutic effectiveness
• To perform epidemiologic surveillance for pulmonary disease
• To assess patients for risk for postoperative pulmonary complications
• To determine pulmonary disability
Contraindications
• acute, unstable cardiopulmonary problems, such as
• hemoptysis,
• pneumothorax,
• myocardial infarction,
• pulmonary embolism, and
• patients with acute chest or abdominal pain should not be tested.
• Patients who have nausea and who have recently vomited
• Recent cataract removal surgery
Lung Volumes and Capacities
• 4 lung volumes and 4 lung capacities

Tidal volume (VT),


Inspiratory reserve volume Total lung capacity
(IRV), Inspiratory capacity
Expiratory reserve volume Vital capacity
(ERV), Functional Residual Capacity
Residual volume
LUNG VOLUMES
• TIDAL VOLUME: Tidal volume (TV) is the volume of air breathed in and
out of lungs in a single normal quiet respiration. Tidal volume signifies
the normal depth of breathing.
• Normal value: 500ml
• INSPIRATORY RESERVE VOLUME: Inspiratory reserve volume (IRV) is
an additional volume of air that can be inspired forcefully after the
end of normal inspiration.
• Normal value: 3,300 ml
• EXPIRATORY RESERVE VOLUME: Expiratory reserve volume is the
additional volume of air that can be expired out forcefully, after
normal expiration.
• Normal value: 1000 ml
• RESIDUAL VOLUME: Residual volume (RV) is the volume of air
remaining in lungs even after forced expiration. Normally, lungs
cannot be emptied completely even by forceful expiration. Some
quantity of air always remains in the lungs even after the forced
expiration.
• Normal value: 1200ml
LUNG CAPACITIES
• INSPIRATORY CAPACITY: Inspiratory capacity (IC) is the maximum
volume of air that is inspired after normal expiration. It includes tidal
volume and inspiratory reserve volume.
• IC = TV + IRV
500 + 3,300 = 3,800 mL
• VITAL CAPACITY: Vital capacity (VC) is the maximum volume of air that
can be expelled out forcefully after a deep inspiration. VC includes
inspiratory reserve volume, tidal volume and expiratory reserve volume.
• VC = IRV + TV + ERV
• = 3,300 + 500 + 1,000 = 4,800 mL
• FUNCTIONAL RESIDUAL CAPACITY: Functional residual capacity (FRC)
is the volume of air remaining in lungs after normal expiration.
Functional residual capacity includes expiratory reserve volume and
residual volume.
• FRC = ERV + RV = 1,000 + 1,200 = 2,200 mL
• TOTAL LUNG CAPACITY:
• Total lung capacity (TLC) is the volume of air present in lungs after a deep
inspiration. It includes all the volumes.
• TLC = IRV + TV + ERV + RV
• = 3,300 + 500 + 1,000 + 1,200 = 6,000 mL
PFT
• INCLUDES:
• SPIROMETRY
• LUNG VOLUMES AND CAPACITIES
• GAS TRANSFER
SPIROMETRY
• SPIROMETRY: Measures of breathing
• Spiro means breathing
• Metry means measurement
• Spirometry is a method of assessing lung function by measuring the
total volumes of air the patient can expel from the lungs after a
maximal inhalation.
• It measure how much and how quickly air can be expelled following
deep breath
• Spirometry is an effort-dependent test that requires careful patient
instruction, understanding, coordination, and cooperation
• Measures:
• Forced vital capacity (FVC)
• Forced expiratory volume in one second. (FEV1)
• FEF25-75 - Forced Expiratory Flow between 25% to 75% of forced vital capacity
• peak expiratory flow rate (PEFR)
• Fev1/FVC
Forced vital capacity
• Volume of air that can be maximally and forcibly expelled from the
lung after a deep inhalation.
• Depends on:
• Lung elasticity
• Size of airways
• Resistance to flow along these airways
Fev1/FVC
• Expressed as percentage
• In normal adult, the ratio ranges from 75%-85%.
• Childrens may have higher flow.
• Obstructive condition: Decreased
• Restrictive condition: Normal or Increase
PEFR
• Maximum rate at which air can be expired after a deep inspiration.
• Normal values: 400L/min
• Measured by peak flow meter
• Pefr reduced in obstructive disease more than restrictive disease.
Before the test- avoid
• Alcohol – 4hours
• Large meal -2 hours
• Smoking – 1hr
• Vigorous exercise- 30 minutes
• Wear loose, comfortable clothing
• Avoid use of bronchodilators
Prior to test
• Gain verbal consent
• Check for contraindication
• Gain accurate height and weight
• Patient should sit comfortable and upright
• Technique in detail should be explained
Spirometry maneuver
• A few normal tidal respiration
• Then deep inspiration
• Breath holding,
• Very forced and fast expiration as hard as patient can
• Then deep, quick and full inspiration.
• Repeat atleast 3 times.
• Take the best readings.
Forced vital capacity
• Possible causes of a decrease in FVC:
• 1. The problem may be with the lung itself. There may have been a
resectional surgical procedure or areas of collapse. Various other
conditions can render the lung less expandable, such as fibrosis,
congestive heart failure, and thickened pleura. Obstructive lung
diseases may reduce the FVC by limiting deflation of the lung.

• 2. The problem may be in the pleural cavity, such as an enlarged


heart, pleural fluid, or a tumor encroaching on the lung.
• 3. Another possibility is restriction of the chest wall. The lung cannot
inflate and deflate normally if the motion of the chest wall (which
includes its abdominal components) is restricted.
• 4. Inflation and deflation of the system require normal function of the
respiratory muscles, primarily the diaphragm, the intercostal muscles,
and the abdominal muscles.
FEV1
• Fev1 is the volume of air exhaled in the first second of the FVC test.
• Normal value depends on patient age, size, sex and race.
• When flow rates are slowed by airway obstruction, as in emphysema,
the FEV1 is decreased by an amount that reflects the severity of the
disease.
• The FVC may also be reduced, although usually to a lesser degree.
FEV1 /FVC
• The FEV1 /FVC ratio is generally expressed as a percentage.
• The amount exhaled during the first second is a fairly constant
fraction of the FVC, irrespective of lung size.
• In the normal adult, the ratio ranges from 75% to 85%, but it
decreases somewhat with aging.
• Children have high flows for their size, and thus, their ratios are
higher, up to 90%.
• Significance:
• It aids in quickly identifying persons with airway obstruction
• The ratio is valuable for identifying the cause of a low FEV
• In pulmonary restriction, the FEV1 and FVC are decreased
proportionally; hence, the ratio is in the normal range, as in the case
of fibrosis.
• How to determine whether airway obstruction or a restrictive:
• A low FEV1 with a normal ratio usually indicates a restrictive process
• A low FEV1 and a decreased ratio signify a predominantly obstructive process.
MAXIMAL VOLUNTARY VENTILATION
• The test for maximal voluntary ventilation (MVV) is an athletic event.
• The subject is instructed to breathe as hard and fast as possible for 10
to 15 seconds.
• The result is extrapolated to 60 seconds and reported in liters per
minute.
• A low MVV can occur in obstructive disease, in restrictive disease, in
neuromuscular disease, in heart disease, in a patient who does not try
or who does not understand, or in a frail patient
MAXIMAL INSPIRATORY FLOW
• With spirometer systems that measure both expiratory and
inspiratory flows, the maximal inspiratory flow (MIF) can be
measured.
• The subject exhales maximally (the FVC test) and then immediately
inhales as rapidly and completely as possible, producing an inspiratory
curve.
• The combined expiratory and inspiratory FV curves form the FV loop.
• Increased airway resistance decreases both maximal expiratory flow
and MIF
Reversibility
• Based on the initial results of baseline spirometry, additional testing
of pulmonary mechanics is often desirable.
• If the baseline test indicates airway obstruction, determining the
reversibility of the obstruction is indicated.
• RTs also use the concept of reversibility when evaluating routine
therapy by performing spirometry before and after therapy.
• In the laboratory, the FVC maneuver is often repeated after the
patient has received a bronchodilator administered by small volume
nebulizer or metered dose inhaler.
• Reversibility of the airway obstruction indicates effective therapy.
• Although improvement in other measurements of pulmonary
function is sometimes used, reversibility is defined as a 15% or
greater improvement in FEV1 and at least a 200-ml increase in FEV1.
• % Improvement = PostFEV1 – PreFEV1/ PreFEV1 * 100
Bronchoprovocation
• When the patient’s history suggests episodic symptoms of hyperreactive
airways and airway obstruction, such as seasonal or exercise-induced
wheezing, and the results of baseline spirometry are normal, performing a
bronchial provocation may be indicated.
• Bronchial provocation testing uses an agent to stimulate a hyperreactive
airway response and to create airway obstruction.
• The procedure usually begins with the patient inhaling a normal saline
aerosol and then repeating the FVC maneuver.
• Some very sensitive patients exhibit hyperreactive airways with saline alone;
a positive response to saline is defined as a decrease in FEV1 of 10% or
greater.
• The methacholine provocation protocol systematically exposes the patient to
increasing dosages of methacholine. Usually starting with a low dose of 0.03
mg/ml, patients inhale methacholine aerosol and then repeat the FVC maneuver.
• A positive response to methacholine is defined as a decrease in FEV1 of 20% or
greater.
• If a positive response does not occur, the methacholine dose is doubled to 0.06
mg/ml, and the FVC maneuver is repeated.
• The process of “double-dosing” and performing FVC maneuvers continues until
there is a positive response or until the full dose, 16 mg/ml, is given.
• If a positive response occurs, treatment with a fast-acting bronchodilator is
indicated, and sometimes administering O2 is helpful
Static lung volume
• The three most commonly used methods of measuring the FRC are
• Nitrogen washout,
• Inert gas dilution, and
• Plethysmography.
Helium Dilution
• The helium dilution technique for measuring lung volumes uses a closed,
rebreathing circuit.
• This technique is based on the assumptions that the patient has no He in his
or her lungs, and that an equilibration of He can occur between the
spirometer and the lungs.
• First, volume (V1) and concentration (C1) of He are measured at the beginning
of the test.
• Next, the valve is turned to connect the patient to the breathing circuit,
usually at the resting expiratory level of the FRC.
• The patient is connected to the He-air mixture, and the concentration of He is
diluted slowly by the patient’s lung volume.
• The patient is connected to the He-air mixture, and the concentration
of He is diluted slowly by the patient’s lung volume.
• Wearing nose clips, the patient breathes normally in the closed circuit.
• Exhaled CO2 is absorbed with soda lime, and O2 is added at a rate
equal to the patient’s O2 consumption.
• A constant volume is maintained to ensure accurate He concentration
measurements.
• The patient rebreathes the gas in the system until equilibrium of He
concentration is established.
• In healthy patients and patients with a small FRC, equilibration occurs
in 2 to 5 minutes.
• Patients with obstructive lung disease may require 20 minutes to
equilibrate because of slow gas mixing in the lungs.
Nitrogen Washout Method
• The nitrogen washout technique uses a nonrebreathing or open
circuit.
• The technique is based on the assumptions that the N concentration
in the lungs is 78% and in equilibrium with the atmosphere, that the
patient inhales 100% O2, and that the O2 replaces all of the N in the
lungs.
• Similar to the He dilution technique, the patient is connected to the
system at FRC.
• The patient’s exhaled gas is monitored, and its volume and N
percentage are measured.
Plethysmography
• The principle of plethysmography is based on Boyle’s law, which states
that the product of the pressure (P) and volume (V) of a gas is
constant under constant temperature conditions.
• The whole-body plethysmograph consists of a sealed chamber in
which the patient sits.
• Pressure transducers (electronic manometers) measure pressure at
the mouth and in the chamber.
• The plethysmographic method measures essentially all the gas in the
lung, including that in poorly ventilated areas.
Diffusing Capacity
• The third major category of pulmonary function testing is measuring
the ability of the lungs to transfer gases across the alveolar-capillary
membrane.
• Vgas = DL× − ( P1-p2 )
• Vgas = Amount of the gas transferred into the lungs
• P1 = Partial pressure of the gas in the alveolus
• P2 = Partial pressure of the gas in the pulmonary capillary
• Carbon monoxide (CO) is the gas normally used to measure the DL.
• The diffusing capacity of the lung for carbon monoxide (DLCO) is
expressed in ml/min/mm Hg under standard temperature and pressure
and dry conditions.
• CO is used as the transfer gas because CO is similar to O2 in important
ways.
• CO and O2 have similar molecular weights and solubility coefficients.
Similar to O2, CO also chemically combines with hemoglobin (Hb).
• CO has a very high affinity for Hb and diffuses rapidly into the pulmonary
blood, keeping the pulmonary capillary partial pressure of CO near zero.
An average normal value is 20 to 30 mL/min/mm Hg; that is, 20 to 30
mL CO is transferred per minute per mm Hg difference in the driving
pressure of CO, namely, the difference between the partial pressure of
CO in alveolar air and blood.
The normal values depend on age, sex , and size.
Causes of Increased Dlco
• 1. Supine position: Rarely is the Dlco measured while the subject is supine, but this
position produces a higher value because of increased perfusion and blood volume
of the upper lobes.
• 2. Exercise: It is difficult to hold one’s breath for 10 seconds during exercise. When
this is done just after exercise, however, Dlco is increased because of increased
pulmonary blood volumes.
• 3. Asthma: Some patients with asthma, especially when symptom-free, have an
increased Dlco, possibly because of more uniform distribution of pulmonary blood
flow.
• 4. Obesity: The Dlco can be increased in obese persons, especially those who are
massively obese. This increase is thought to be due to an increased pulmonary
blood volume.

You might also like